STOCK TITAN

Endo to Report Second Quarter 2025 Financial Results on August 6, 2025

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Endo (OTCQX: NDOI) has scheduled its second quarter 2025 financial results announcement for August 6, 2025, before the market opens. The company will host a conference call at 8:00 a.m. ET on the same day.

Investors can access the audio webcast through the company's Investor Relations website at investor.endo.com. For those preferring a conference line, dial-in numbers are provided: 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (international). Participants should join 10 minutes before the start time. A webcast replay will be available after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

+3.09%
1 alert
+3.09% News Effect

On the day this news was published, NDOI gained 3.09%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MALVERN, Pa., July 21, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will report second quarter 2025 financial results on August 6, 2025, prior to market open. The Company will host a conference call on the same day at 8:00 a.m. ET.

The audio webcast may be accessed through the Investor Relations section of the Company's website at investor.endo.com under Events & Presentations. To access the call through a conference line, participants may dial 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.). Participants are advised to join 10 minutes prior to the scheduled start time. A replay of the webcast will be available following the event.

About Endo
Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/endo-to-report-second-quarter-2025-financial-results-on-august-6-2025-302509530.html

SOURCE Endo, Inc.

FAQ

When will Endo (NDOI) release Q2 2025 earnings?

Endo will release its Q2 2025 financial results on August 6, 2025, before the market opens.

What time is Endo's Q2 2025 earnings conference call?

Endo's Q2 2025 earnings conference call is scheduled for August 6, 2025 at 8:00 a.m. ET.

How can I access Endo's Q2 2025 earnings call?

You can access the call via webcast at investor.endo.com or by dialing 800-836-8184 (U.S./Canada) or 646-357-8785 (international).

Will there be a replay of Endo's Q2 2025 earnings call?

Yes, a replay of the webcast will be available on Endo's website following the event.
Endo Inc

OTC:NDOI

NDOI Rankings

NDOI Latest News

NDOI Stock Data

1.80B
40.36M
0.16%
72.13%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Malvern